Hudson Therapeutics, a leading innovator in therapeutic solutions and a US subsidiary of Shaperon, announced Shaperon’s entry ...

ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ: IPA), ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") ...

Finnish pharmaceutical company Orion has entered a partnership with Aitia to leverage artificial intelligence in drug ...

Phare Bio, along with the Collins Lab at the Massachusetts Institute of Technology (MIT) and Harvard's Wyss Institute, today ...

Evaxion and MSD have been collaborating on EVX-B3 since 2023. Also in 2023, MSD, through its Global Health Innovation Fund (MGHIF), led a private placement round of financing for Evaxion to become the ...

Danish clinical-stage AI-based vaccine developer Evaxion Biotech (Nasdaq: EVAX) has entered into an option and license ...

EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting ...

PRNewswire/ -- "According to the latest BCC Research study, the demand for "Artificial Intelligence (AI) in Life Sciences ...

The success of clinical trials hinges on a complex array of factors, many of which extend beyond traditional clinical care. In the age of AI, large data sets – like the treasure trove of ...

Bio-Techne Corporation today announced that one of its spatial biology brands, Lunaphore, is partnering with Discovery Life Sciences (Discovery) to add Lunaphore COMETtm, a best-in-class spatial ...

EDETEK Inc., a leading global provider of specialized software and services for the biopharma, devices, and diagnostics industries, announced today that it will present at the 2024 The Society for ...

Anant Madabhushi, PhD, executive director for the Emory Empathetic AI for Health Institute, proposes AI-based solutions to address health care disparities, emphasizing systemic racism and phenotypic ...